Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance. Ceredigion and Mid Wales Trust Data per Bed Days

Similar documents
Board Meeting Agenda Item: 7.2 Paper No: Purpose: For Information. Healthcare Associated Infection Report

Medical Director Board Paper No. 10/43. Healthcare Associated Infection Reporting Template (HAIRT)

Healthcare-associated infections surveillance report

Staphylococcus aureus and Health Care associated Infections

Multi-Drug Resistant Organisms (MDRO)

European Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004

Healthcare-associated infections surveillance report

Medical Director Board Paper No. 11/34. Healthcare Associated Infection Reporting Template (HAIRT)

Can you treat mrsa with amoxicillin

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Doxycycline staph aureus

An audit of the quality of antimicrobial prescribing

Mrsa abscess and cellulitis

Freedom of Information

Promoting Appropriate Antimicrobial Prescribing in Secondary Care

Post-operative surgical wound infection

Today s Agenda: 9/30/14

WELSH HEALTH CIRCULAR

What s happening across the UK with antimicrobial prescribing quality indicators?

FREEDOM OF INFORMATION ACT

ANTIMICROBIAL STEWARDSHIP IN SCOTLAND. Key achievements of the Scottish Antimicrobial Prescribing Group

Beef Calving Statistics (01/07/ /06/2016)

Quality and Safety Committee

Controlling MRSA in the healthcare setting An achievable goal?

DISEASE MONITORING AND EXTENSION SYSTEM FOR THE SOUTH AFRICAN DAIRY INDUSTRY

Hospital Acquired Infections in the Era of Antimicrobial Resistance

Monthly Economic Review November 2017

Prescribing Quality Scheme 2017/18

List of Seminars and invited special lectures delivered on behalf of GMERF

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

Lecture Notes: The Importance of Nurse Empowerment. Theme: It is not the Nurses Fault

Infection control in intensive care. Sandra Fairley Senior Nurse, Neurocritical Care

About MRSA. MRSA (sometimes referred to as a superbug) stands for meticillin resistant Staphylococcus aureus.

Benchmarking Antimicrobial Use

Understanding MRSA. 1. MRSA: An Overview The Rise of Antibiotic-Resistant Infections MRSA Infections Are Increasing 30 Among Teenagers

Eddie Chi Man Leung, May Kin Ping Lee, and Raymond Wai Man Lai. 1. Introduction

Rapid molecular testing to detect Staphylococcus aureus in positive blood cultures improves patient management. Martin McHugh Clinical Scientist

Animal Care, Control and Adoption

Zimbabwe Poultry Association

Animal Care, Control and Adoption

running head: SUPERBUGS Humphreys 1

A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus

Antibacterial Usage in Primary Care In Wales 2013/ /18

Success for a MRSA Reduction Program: Role of Surveillance and Testing

Use of monthly collected milk yields for the early detection of vector-borne emerging diseases.

Animal Care, Control and Adoption

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

New Washable SPILLSEAL Keyboards. How they can reduce MRSA in your hospital

Antibacterial Resistance In Wales

Animal Care, Control and Adoption

Can we trust the Xpert?

Screening programmes for Hospital Acquired Infections

Antibacterial Resistance in Wales

Quality indicators and outcomes in the devolved nations Scotland

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts

4-H LIVESTOCK RECORD BOOK

Doxycycline for strep pneumonia

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

Newaygo County Swine Record Book 2018

Antimicrobial Susceptibility Patterns

ANIMAL RABIES IN NEPAL AND RACCOON RABIES IN ALBANY COUNTY, NEW YORK

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Ready to Launch: Antimicrobial Stewardship for All!

STATUS OF THE DUCK INDUSTRY IN 2012 AND PROSPECTS FOR 2013

Clostridium difficile Surveillance Report 2016

MRSA in the United Kingdom status quo and future developments

MRSA Outbreak in Firefighters

MRSA: How to Keep This Deadly Super Bug From Infecting You

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

Antibacterial Resistance In Wales

Poultry Pocketbook 2018

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

MRSA Screening (Elective Patients)

The relevance of Gram-negative pathogens for public health situation in India

Landfill Dogs by Shannon Johnstone

Rabbits and hares (Lagomorpha)

Landfill Dogs by Shannon Johnstone

Infection Control of Emerging Diseases

Int.J.Curr.Microbiol.App.Sci (2016) 5(12):

The Hike in Core Consumer Price Index is Temporary May 15, 2009

Figure 1: Comparison of District Monthly Rainfall

Figure 1: Comparison of District Monthly Rainfall

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Figure 1: Comparison of District Monthly Rainfall

range of RA s accessible during the night.

range of RA s accessible during the night.

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

Landfill Dogs by Shannon Johnstone

Healthcare-associated Infections Annual Report December 2018

A Project of Peaceful Kingdom, a 501(c)3 organization

MOON PHASES FOR 2018, at Kitt Peak Times and dates are given in local time, zone = 7 hr West. They are generally better than +- 2 minutes.

MOON PHASES FOR 2019, at Kitt Peak Times and dates are given in local time, zone = 7 hr West. They are generally better than +- 2 minutes.

Landfill Dogs by Shannon Johnstone

Great Lakes Animal Welfare Conference October 2015 Starting a Kitten Nursery

Figure 1: Comparison of District Monthly Rainfall

Situation update of dengue in the SEA Region, 2010

Summary of the latest data on antibiotic resistance in the European Union

Icd 10 code for bacteremia with mssa

Landfill Dogs by Shannon Johnstone

Transcription:

Staphylococcus aureus Blood Stream Infection (Bacteraemia) Surveillance Ceredigion and Mid Wales Trust Data per 100 000 Bed Days Commentary: Staphylococcus aureus is a bacterium that a proportion (up to 30%) of the healthy population carry in their nose or in other moist parts of the body. Commonly Staph. aureus causes infections such as boils and infected skin wounds. It can cause pneumonia, urinary tract infections and blood stream infections (bacteraemia) both in the community and in hospital practice. In general terms there are two types of Staph. aureus methicillin sensitive Staph. aureus (MSSA) and methicillin resistant Staph. aureus (MRSA). This simply tells us whether the organism is sensitive or resistant to the commonly used antibiotic flucloxacillin. MRSA stands for methicillin Resistant Staphylococcus aureus (MRSA). It is a type of Staphylcoccus aureus (Staph. aureus) that has become resistant to various antibiotics including flucloxacillin. The infections it causes are the same as those caused by any other Staphylcoccus aureus bacterium. The media are fond of referring to it as the superbug ; however, MRSA is no more of a super bug than ordinary Staph. aureus (MSSA). The absolute numbers of patients diagnosed with MRSA bacteraemia in the Trust are very low, and this simply reflects the patient groups/mix treated. Not all of these bacteraemias are acquired in hospital; some are the reason for admission to hospital. There are very effective antibiotics available to us in hospitals with which we can treat MRSA.

Rates of Staphylococcus aureus Blood Stream Infections per 100 000 For the Staphylococcus aureus blood stream infection (bacteraemia) surveillance scheme, rates produced for reports have historically used 1000 as the standard comparison denominator. However, the Top Ten Blood Stream Infection (bacteraemia) surveillance uses 100 000 as the standard comparison denominator. To allow comparisons between the two schemes, the Staph. aureus data published for each Trust has been recalculated to be per 100 000. However to allow comparison with the English scheme, which is presented per 10,000 please divide these Welsh Trust figures by 10. Blood Culture Sets Taken (BCS) Positive Blood Cultures (PBS)* Ceredigion & Mid Wales Annual Data: 01/10/04 30/09/05 Total S.aureus MRSA Bed days % of BCS that are MRSA % of PBS that are MRSA % of S.aureus that are MRSA BCS/100 000 PBS/100 000 Total S.aureus /100 000 MRSA/100 000 1695 256 14 6 63920 0.35 2.34 42.86 2652 401 22 9 *Including duplicates and contaminants Quarter Apr 01 - Jun 01 1 0 Jul 01 - Sep 01 2 0 Oct 01 - Dec 01 3 0 Jan 02 - Mar 02 4 2 Apr 02 - Jun 02 5 2 Jul 02 - Sep 02 6 1 Oct 02 - Dec 02 7 0 Jan 03 - Mar 03 8 3 Apr 03 - Jun 03 9 1 Jul 03 - Sep 03 10 0 Oct 03 - Dec 03 11 1 Jan 04 - Mar 04 12 0 Apr 04-Jun 04 13 1 Jul 04 - Sep 04 14 1 Oct 04 - Dec 04 15 2 Jan 05 - Mar 05 16 2 Apr 05 - Jun 05 17 2 Jul 05 - Sep 05 18 0 Ceredigion & Mid Wales Quarterly Trend Data: 01/04/01 30/09/05 Quarter no MRSA MSSA Total S. aureus Bed days MRSA/100 000 MSSA/100 000 SA/100 000 1 1 16528 0 6 6 3 3 16871 0 18 18 2 2 16106 0 12 12 2 4 16738 12 12 24 1 3 15502 13 6 19 1 2 15425 6 6 13 0 0 15402 0 0 0 3 6 16388 18 18 37 2 3 15330 7 13 20 2 2 15819 0 13 13 0 1 16181 6 0 6 4 4 16834 0 24 24 4 5 16745 6 24 30 0 1 16705 6 0 6 3 5 16166 12 19 31 3 5 16928 12 18 30 0 2 15887 13 0 13 2 2 14843 0 13 13

Ceredigion & Mid Wales Trust Statistical Process Control Charts for Rates of S. aureus Blood Stream Infections per 100 000 Bed Days Data from the Staphylococcus aureus blood stream infection (bacteraemia) surveillance are used to produce statistical process control (SPC) charts. These compare a Trust s rate of infection with calculated upper and lower control limits, which allow natural variation in rates to be distinguished from situations where something unusual is occurring. SPC charts are used to compare rates within a Trust over time and between equivalent Trusts at a given point in time. Trusts are asked to investigate if their rates fall outside the control limits of the SPC charts. More information about the statistical analyses performed on the Staph. aureus data and what the results mean is provided in the section on the Staph. aureus Blood Stream Infections surveillance scheme.

SPC Chart for Quarterly S. aureus Blood Stream (Bacteraemia) Rates in Ceredigion & Mid Wales Trust: 01/04/01 30/09/05

SPC Chart for Quarterly MSSA Blood Stream (Bacteraemia) Rates in Ceredigion & Mid Wales Trust: 01/04/01 30/09/05

SPC Chart for Quarterly MRSA Blood Stream (Bacteraemia) Rates in Ceredigion & Mid Wales Trust: 01/04/01 30/09/05